Skip to main content
SpringerLink
Log in

Biologic Treatment in Tendon and Muscle Injuries

  • Chapter
  • First Online:
The Sports Medicine Physician

  • 2313 Accesses

Abstract

In the last decades, we have observed a great increase in the number of people practicing sports around the world. However, these beneficial effects must be balanced with injuries that are to some extent unavoidable. Muscle and tendon injuries are very common in sports practice. Despite the enormous advances in medicine in recent decades, the treatment of muscle injuries has changed little. Some biological treatments have been studied with promising initial results: platelet-rich plasma (PRP), mesenchymal cells, losartan, prolotherapy, and gene therapy. But further investigations are required to better define indication techniques, modalities, safety, and cost-effectiveness.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Arliani GG, Astur DC, Yamada RK, Yamada AF, da Rocha Correa Fernandes A, Ejnisman B, et al. Professional football can be considered a healthy sport? Knee Surg Sports Traumatol Arthrosc. 2016;24(12):3907–11.

    Article  Google Scholar 

  2. Maffulli N, Longo UG, Gougoulias N, Caine D, Denaro V. Sport injuries: a review of outcomes. Br Med Bull. 2011;97:47–80.

    Article  Google Scholar 

  3. Nicholl JP, Coleman P, Williams BT. The epidemiology of sports and exercise related injury in the United Kingdom. Br J Sports Med. 1995;29(4):232–8.

    Article  CAS  Google Scholar 

  4. Lindqvist KS, Timpka T, Bjurulf P. Injuries during leisure physical activity in a Swedish municipality. Scand J Soc Med. 1996;24(4):282–92.

    Article  CAS  Google Scholar 

  5. Galer BS, Rowbotham M, Perander J, Devers A, Friedman E. Topical diclofenac patch relieves minor sports injury pain: results of a multicenter controlled clinical trial. J Pain Symptom Manage. 2000;19(4):287–94.

    Article  CAS  Google Scholar 

  6. Jarvinen TA, Jarvinen TL, Kaariainen M, Aarimaa V, Vaittinen S, Kalimo H, et al. Muscle injuries: optimising recovery. Best Pract Res Clin Rheumatol. 2007;21(2):317–31.

    Article  Google Scholar 

  7. Ekstrand J, Hagglund M, Walden M. Epidemiology of muscle injuries in professional football (soccer). Am J Sports Med. 2011;39(6):1226–32.

    Article  Google Scholar 

  8. Woods C, Hawkins R, Hulse M, Hodson A. The Football Association Medical Research Programme: an audit of injuries in professional football-analysis of preseason injuries. Br J Sports Med. 2002;36(6):436–41; discussion 41.

    Article  CAS  Google Scholar 

  9. Manning MR, Levy RS. Soccer. Phys Med Rehabil Clin N Am. 2006;17(3):677–95, vii.

    Article  Google Scholar 

  10. Huard J, Lu A, Mu X, Guo P, Li Y. Muscle injuries and repair: what’s new on the horizon! Cells Tissues Organs. 2016;202(3–4):227–36.

    Article  Google Scholar 

  11. Andrade BM, Baldanza MR, Ribeiro KC, Porto A, Pecanha R, Fortes FS, et al. Bone marrow mesenchymal cells improve muscle function in a skeletal muscle re-injury model. PLoS One. 2015;10(6):e0127561.

    Article  Google Scholar 

  12. Filardo G, Kon E, Roffi A, Di Matteo B, Merli ML, Marcacci M. Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration. Knee Surg Sports Traumatol Arthrosc. 2015;23(9):2459–74.

    Article  CAS  Google Scholar 

  13. Malanga G, Abdelshahed D, Jayaram P. Orthobiologic interventions using ultrasound guidance. Phys Med Rehabil Clin N Am. 2016;27(3):717–31.

    Article  Google Scholar 

  14. Andia I, Abate M. Platelet-rich plasma in the treatment of skeletal muscle injuries. Expert Opin Biol Ther. 2015;15(7):987–99.

    Article  CAS  Google Scholar 

  15. Vidal B, Serrano AL, Tjwa M, Suelves M, Ardite E, De Mori R, et al. Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. Genes Dev. 2008;22(13):1747–52.

    Article  CAS  Google Scholar 

  16. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27(3):158–67.

    Article  CAS  Google Scholar 

  17. DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy. 2012;28(7):998–1009.

    Article  Google Scholar 

  18. Delos D, Leineweber MJ, Chaudhury S, Alzoobaee S, Gao Y, Rodeo SA. The effect of platelet-rich plasma on muscle contusion healing in a rat model. Am J Sports Med. 2014;42(9):2067–74.

    Article  Google Scholar 

  19. MS AH, Mohamed Ali MR, Yusof A, George J, Lee LP. Platelet-rich plasma injections for the treatment of hamstring injuries: a randomized controlled trial. Am J Sports Med. 2014;42(10):2410–8.

    Article  Google Scholar 

  20. Martinez-Zapata MJ, Orozco L, Balius R, Soler R, Bosch A, Rodas G, et al. Efficacy of autologous platelet-rich plasma for the treatment of muscle rupture with haematoma: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Blood Transfus. 2016;14(2):245–54.

    PubMed  PubMed Central  Google Scholar 

  21. Grassi A, Napoli F, Romandini I, Samuelsson K, Zaffagnini S, Candrian C, et al. Is platelet-rich plasma (PRP) effective in the treatment of acute muscle injuries? A systematic review and meta-analysis. Sports Med. 2018;48(4):971–89.

    Article  Google Scholar 

  22. Andia I, Maffulli N. Muscle and tendon injuries: the role of biological interventions to promote and assist healing and recovery. Arthroscopy. 2015;31(5):999–1015.

    Article  Google Scholar 

  23. Noonan TJ, Garrett WE Jr. Muscle strain injury: diagnosis and treatment. J Am Acad Orthop Surg. 1999;7(4):262–9.

    Article  CAS  Google Scholar 

  24. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7.

    Article  CAS  Google Scholar 

  25. Iyer SS, Rojas M. Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies. Expert Opin Biol Ther. 2008;8(5):569–81.

    Article  CAS  Google Scholar 

  26. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726–36.

    Article  CAS  Google Scholar 

  27. Mori R, Kamei N, Okawa S, Nakabayashi A, Yokota K, Higashi Y, et al. Promotion of skeletal muscle repair in a rat skeletal muscle injury model by local injection of human adipose tissue-derived regenerative cells. J Tissue Eng Regen Med. 2015;9(10):1150–60.

    Article  CAS  Google Scholar 

  28. Lim DS, Lutucuta S, Bachireddy P, Youker K, Evans A, Entman M, et al. Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. Circulation. 2001;103(6):789–91.

    Article  CAS  Google Scholar 

  29. Paizis G, Gilbert RE, Cooper ME, Murthi P, Schembri JM, Wu LL, et al. Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol. 2001;35(3):376–85.

    Article  CAS  Google Scholar 

  30. Suga S, Mazzali M, Ray PE, Kang DH, Johnson RJ. Angiotensin II type 1 receptor blockade ameliorates tubulointerstitial injury induced by chronic potassium deficiency. Kidney Int. 2002;61(3):951–8.

    Article  CAS  Google Scholar 

  31. Bedair HS, Karthikeyan T, Quintero A, Li Y, Huard J. Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle. Am J Sports Med. 2008;36(8):1548–54.

    Article  Google Scholar 

  32. Kobayashi T, Uehara K, Ota S, Tobita K, Ambrosio F, Cummins JH, et al. The timing of administration of a clinically relevant dose of losartan influences the healing process after contusion induced muscle injury. J Appl Physiol (1985). 2013;114(2):262–73.

    Article  CAS  Google Scholar 

  33. Terada S, Ota S, Kobayashi M, Kobayashi T, Mifune Y, Takayama K, et al. Use of an antifibrotic agent improves the effect of platelet-rich plasma on muscle healing after injury. J Bone Joint Surg Am. 2013;95(11):980–8.

    Article  Google Scholar 

  34. Kobayashi M, Ota S, Terada S, Kawakami Y, Otsuka T, Fu FH, et al. The combined use of losartan and muscle-derived stem cells significantly improves the functional recovery of muscle in a young mouse model of contusion injuries. Am J Sports Med. 2016;44(12):3252–61.

    Article  Google Scholar 

  35. Evans C. Using genes to facilitate the endogenous repair and regeneration of orthopaedic tissues. Int Orthop. 2014;38(9):1761–9.

    Article  Google Scholar 

  36. Ginn SL, Alexander IE, Edelstein ML, Abedi MR, Wixon J. Gene therapy clinical trials worldwide to 2012—an update. J Gene Med. 2013;15(2):65–77.

    Article  CAS  Google Scholar 

  37. Schertzer JD, Lynch GS. Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury. Gene Ther. 2006;13(23):1657–64.

    Article  CAS  Google Scholar 

  38. Li Y, Li J, Zhu J, Sun B, Branca M, Tang Y, et al. Decorin gene transfer promotes muscle cell differentiation and muscle regeneration. Mol Ther. 2007;15(9):1616–22.

    Article  CAS  Google Scholar 

  39. Evans CH, Huard J. Gene therapy approaches to regenerating the musculoskeletal system. Nat Rev Rheumatol. 2015;11(4):234–42.

    Article  CAS  Google Scholar 

  40. Zhou Y, Zhang J, Wu H, Hogan MV, Wang JH-C. The differential effects os leukocyte-containing and pure platelet-rich plasma (PRP) on tendon stem/progenitor cells—implication of PRP application for the clinical treatment of tendon injuries. Stem Cell Res Ther. 2015;6:173.

    Article  Google Scholar 

  41. Kannus P, Natri A. Etiology and patophysiology of tendon ruptures in sports. Scand J Med Sci Sports. 1997;7:107–12.

    Article  CAS  Google Scholar 

  42. Fitzpatrick J, Bulsara M, Zheng MH. The effectiveness of platelet-rich plasma in the treatment of tendinopathy: a meta-analysis of randomized controlled clinical trials. Am J Sports Med. 2016;45(1):226–33.

    Article  Google Scholar 

  43. Docheva D, Müller SA, Majewski M, et al. Biologics for tendon repair. Adv Drug Deliv Rev. 2015;84:222–39.

    Article  CAS  Google Scholar 

  44. Ambrosio F, Wolf SL, Delitto A, et al. The emerging relationship between regenerative medicine and physical therapeutics. Phys Ther. 2010;90(12):1807–14.

    Article  Google Scholar 

  45. Andia I, Martin JI, Maffulli N. Advances with platelet rich plasma therapies for tendon regeneration. Expert Opin Biol Ther. 2018;18(4):389–98.

    Article  Google Scholar 

  46. Ahmad Z, Brooks R, Kang SN, et al. The effect of platelet-rich plasma on clinical outcomes in lateral epicondylitis. Arthroscopy. 2013;29(11):1851–62.

    Article  Google Scholar 

  47. Baksh N, Hannon CP, Murawski CD, Smyth NA, Kennedy JG. Platelet-rich plasma in tendon models: a systematic review of basic science literature. Arthroscopy. 2013;29(3):596–607.

    Article  Google Scholar 

  48. de Vos RJ, van Veldhoven PL, Moen MH, Weir A, Tol JL, Maffulli N. Autologous growth factor injections in chronic tendinopathy: a systematic review. Br Med Bull. 2010;95:63–77.

    Article  Google Scholar 

  49. de Vos RJ, Windt J, Weir A. Strong evidence against platelet-rich plasma injections for chronic lateral epicondylar tendinopathy: a systematic review. Br J Sports Med. 2014;48(12):952–6.

    Article  Google Scholar 

  50. Krogh TP, Bartels EM, Ellingsen T, et al. Comparative effectiveness of injection therapies in lateral epicondylitis: a systematic review and network meta-analysis of randomized controlled trials. Am J Sports Med. 2013;41(6):1435–46.

    Article  Google Scholar 

  51. Moraes VY, Lenza M, Tamaoki MJ, Faloppa F, Belloti JC. Platelet- rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev. 2014;4:CD010071.

    Google Scholar 

  52. Giai Via A, McCarthy MB, de Girolamo L, Ragni E, Oliva F, Maffulli N. Making them commit: strategies to influence phenotypic differentiation in mesenchymal stem cells. Sports Med Arthrosc Rev. 2018;26(2):64–9.

    Article  Google Scholar 

  53. Leo AJ, Grande DA. Mesenchymal stem cells in tissue engineering. Cells Tissues Organs. 2006;183:112–22.

    Article  CAS  Google Scholar 

  54. Rosenbaum AJ, Grande DA, Dines JS. The use of mesenchymal stem cells in tissue engineering: a global assessment. Organogenesis. 2008;4:23–7.

    Article  Google Scholar 

  55. Chaudhury S. Mesenchymal stem cell applications to tendon healing. Muscles Ligaments Tendons J. 2012;2(3):222–9.

    PubMed  PubMed Central  Google Scholar 

  56. Liu L, Hindieh J, Leong DJ, Sun HB. Advances of stem cell based-therapeutic approaches for tendon repair. J Orthop Translat. 2017;9:69–75.

    Article  CAS  Google Scholar 

  57. Lee SY, Kim W, Lim C, et al. Treatment of lateral epicondylosis by using allogeneic adipose-derived mesenchymal stem cells: a pilot study. Stem Cells. 2015;33:2995–3005.

    Article  CAS  Google Scholar 

  58. Connell D, Datir A, Alyas F, et al. Treatment of lateral epicondylitis using skin-derived tenocyte-like cells. Br J Sports Med. 2009;43:293–8.

    Article  CAS  Google Scholar 

  59. Clarke AW, Alyas F, Morris T, et al. Skin-derived tenocyte-like cells for the treatment of patellar tendinopathy. Am J Sports Med. 2011;39:614–23.

    Article  Google Scholar 

  60. Lin J, Zhou W, Han S, Bunpetch V, Zhao K, Yin Z, Ouyang H. Cell-materail interactions in tendon tissue engineering. Acta Biomater. 2018;70:1–11.

    Article  Google Scholar 

  61. Majewski M, Heisterbach P, Jaquiéry C, et al. Improved tendon healing using bFGF, BMP-12 and TGFβ1 in a rat model. Eur Cell Mater. 2018;35:318–34.

    Article  CAS  Google Scholar 

  62. Rabago D, Slattengren A, Zgierska A. Prolotherapy in primary care practice. Prim Care. 2010;37:65–80.

    Article  Google Scholar 

  63. Freeman J, Empson Y, Ekwueme E, Paynter D, Bsolinson P. Effect of prolotherapy on cellular proliferation and collagen deposition in MC3T3-E1 and patellar tendon fibroblast populations. Transl Res. 2011;158:132–9.

    Article  CAS  Google Scholar 

  64. Rabago D, Best T, Beamsley M, Patterson J. A systematic review of prolotherapy for chronic musculoskeletal pain. Clin Sports Med. 2005;15(5):376–80.

    Article  Google Scholar 

  65. Yelland M, Sweeting K, Lyftogt J, Ng SK, Scuffham P, Evans K. Prolotherapy injections and eccentric loading exercises for painful Achilles tendinosis: a randomized trial. Br J Sports Med. 2011;45:421–8.

    Article  Google Scholar 

  66. Kim E, Lee J. Autologous platelet rich plasma versus dextrose prolotherapy for the treatment of chronic recalcitrant plantar fasciitis. Phys Med Rehabil Int. 2014;6:152–8.

    Google Scholar 

  67. Ryan M, Wong A, Gillies J, Wong J, Taunton J. Sonographically guided intratendinous injections of hyperosmolar dextrose/lidocaine: a pilot study for the treatment of chronic plantar fasciitis. Br J Sports Med. 2009;43:303–68.

    Article  CAS  Google Scholar 

  68. Scarpone M, Rabago DP, Zgierska A, Arbogast G, Snell E. The efficacy of prolotherapy for lateral epicondylosis: a pilot study. Clin Sports Med. 2008;18(3):248–54.

    Article  Google Scholar 

  69. Bertrand H, Reeves KD, Bennett CJ, et al. Dextrose prolotherapy versus control injections in painful rotator cuff tendinopathy. Arch Phys Med Rehabil. 2016;97:17–25.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopedics and Traumatology, UNIFESP, São Paulo, Brazil

    Moises Cohen & Gustavo Gonçalves Arliani

  2. Cohen Institute, São Paulo, São Paulo, Brazil

    Camila Cohen Kaleka

  3. Hospital Israelista Albert Einstein, São Paulo, Brazil

    Camila Cohen Kaleka

Authors
  1. Moises Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gustavo Gonçalves Arliani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Camila Cohen Kaleka
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Orthopedics and Traumatology, State University of Campinas – UNICAMP, Campinas / Sao Paulo, Brazil

    Sérgio Rocha Piedade

  2. Orthopaedic Sports Medicine, University of Munich (TUM), München, Bayern, Germany

    Andreas B. Imhoff

  3. Ascot Hospital, Auckland, New Zealand

    Mark Clatworthy

  4. Department of Orthopedics & Traumatology, Federal University of São Paulo, Vila Clementino - São Paulo, São Paulo, Brazil

    Moises Cohen

  5. Espregueira-Mendes Sports Centre, Clínica do Dragão, Porto, Portugal

    João Espregueira-Mendes

Rights and permissions

Reprints and permissions

Copyright information

© 2019 ISAKOS

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cohen, M., Arliani, G.G., Kaleka, C.C. (2019). Biologic Treatment in Tendon and Muscle Injuries. In: Rocha Piedade, S., Imhoff, A., Clatworthy, M., Cohen, M., Espregueira-Mendes, J. (eds) The Sports Medicine Physician. Springer, Cham. https://doi.org/10.1007/978-3-030-10433-7_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-10433-7_42

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-10432-0

  • Online ISBN: 978-3-030-10433-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation